Researchers published an additional-findings update on September 9, 2026, identifying 12 more websites that AI agents they ...

To random passersby, late summer afternoons along Green Street in West Salem look, sound, and feel like many others found in ...

Gemini and Claude both built impressive offline utility apps, but only one consistently got the details right.

The Blood of Dawnwalker feels like a visitor from an alternate universe, where all of the energy, creativity, and ...

A phishing campaign that has been targeting hotels across Europe and Asia since April 2026 is exploiting a fundamental flaw in how enterprise email security works — routing malicious messages through ...

Who in the world is Elias Thorne? He’s a regular fixture in stories told by chatbots, as first spotted by software engineer Daniel May, but no one knows why… until now. According to a new preprint ...

ChatGPT and Gemini are AI assistants that generate human-like responses to user inputs and help with both complex and everyday tasks. ChatGPT performs better in textual content creation, creative ...

It used to be easy enough to distinguish between human-made and AI-generated imagery — just two years ago, you couldn’t use image models to create a menu for a Mexican restaurant without inventing new ...

Researchers say they’ve discovered a supply-chain attack flooding repositories with malicious packages that contain invisible code, a technique that’s flummoxing traditional defenses designed to ...

Laurence Wall is a Contributor at DualShockers who has been writing professionally since 2022 and covering games since 2023. He primarily writes guides and lists, with a focus on indie games, RPGs, ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...